Efficacy and safety of zinc and hyaluronic acid in male patients with ejaculate volume reduction: a prospective, randomized, placebo-controlled, comparative clinical trial
Not Applicable
Terminated
- Conditions
- Diseases of the genitourinary system
- Registration Number
- KCT0004369
- Lead Sponsor
- Koera University Guro Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Terminated
- Sex
- Male
- Target Recruitment
- 54
Inclusion Criteria
1.A male patient with a reduction in ejaculatory volume
2.Those who voluntarily agreed to participate in this study
Exclusion Criteria
1. Patients diagnosed with diabetes
2. Patients diagnosed with prostate cancer
3. Patients with a history of prostate surgery
4. Patients who have been receiving testosterone replacement therapy (TRT) or who have been treated with TRT within 3 months prior to randomization
5. Patients who have experienced drug use, surgery, or procedure that the investigator has determined could affect the ejaculatory ability
6. Those who are difficult to follow up to 3 months after the start of the study
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method average of MSHQ-EjD-SF Q3 score (ejaculate volume) change
- Secondary Outcome Measures
Name Time Method average of MSHQ-EjD-SF total score (Q1-Q3) change;average of MSHQ-EjD-SF Q4 score (bother/satisfaction) change;IIEF Q9 and Q10 (orgasmic function domain score);Serum testosterone change;adverse effect;laboratory test result